Who are Bioregen's investors?

Bioregen's investors include Eight Roads Ventures, F-Prime Capital.

Where is Bioregen headquartered?

Bioregen is headquartered in Changzhou, CN.

Bioregen

Changzhou, CN · 2 known investors

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.

Biotech Medical Devices New Materials

Investors · 2

Eight Roads VenturesMumbai · $5M – $30M

F-Prime CapitalCambridge · $3M – $10M

Competitors · 1

by search overlap

BioRegenx4 shared keywordsBioRegenx is a health-technology holding company developing and acquiring patented regenerative biotherapeutics, anti-aging nutraceuticals, and AI-based health monitoring tools, including non-invasive microvascular imaging (GlycoCheck), a plant-based supplement (Endocalyx Pro), and contactless vital-sign analysis (DocSun). It sells through direct-to-institution, direct-to-practitioner, and direct-to-consumer models across the health, wellness, and longevity market.

Companies competing with Bioregen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Bioregen do?: BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.
Who are Bioregen's investors?: Bioregen's investors include Eight Roads Ventures, F-Prime Capital.
Where is Bioregen headquartered?: Bioregen is headquartered in Changzhou, CN.